DLB
Dolby Laboratories, Inc. NYSE$57.46
Mkt Cap $5.6B
52w Low $57.62
-0.8% of range
52w High $78.28
50d MA $62.63
200d MA $67.19
P/E (TTM)
21.6x
EV/EBITDA
16.6x
P/B
2.1x
Debt/Equity
0.0x
ROE
9.3%
P/FCF
16.1x
RSI (14)
—
ATR (14)
—
Beta
0.86
50d MA
$62.63
200d MA
$67.19
Avg Volume
685.3K
About
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digi…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.31 | 1.37 | +4.6% | 64.14 | -6.4% | -10.4% | — | — | — | — | — | — |
| Jan 29, 2026 | AMC | 0.99 | 1.06 | +6.7% | 63.03 | -0.4% | +1.8% | +2.3% | -3.1% | +2.3% | +1.5% | +3.3% | — |
| Nov 18, 2025 | AMC | 0.70 | 0.99 | +41.6% | 64.96 | -1.2% | +0.1% | +0.8% | +3.9% | +2.8% | +3.7% | +2.8% | — |
| Jul 31, 2025 | AMC | 0.71 | 0.78 | +9.2% | 75.34 | -3.0% | -7.0% | -3.9% | -3.7% | -4.0% | -4.5% | -4.3% | — |
| May 1, 2025 | AMC | 1.27 | 1.34 | +5.5% | 76.18 | -4.3% | -1.7% | -1.9% | -2.5% | -3.6% | -1.6% | -2.9% | — |
| Jan 29, 2025 | AMC | 1.12 | 1.14 | +1.8% | 80.63 | +2.9% | +8.3% | +3.8% | +4.4% | +4.6% | +4.7% | +1.2% | — |
| Nov 19, 2024 | AMC | 0.70 | 0.81 | +15.7% | 70.91 | +6.5% | +15.6% | +13.2% | +13.6% | +13.2% | +13.3% | +9.3% | — |
| Aug 7, 2024 | AMC | 0.30 | 0.71 | +132.8% | 73.22 | -1.5% | -7.2% | -7.7% | -8.8% | -5.2% | -4.2% | -6.5% | — |
| May 2, 2024 | AMC | 1.19 | 1.27 | +6.7% | 79.71 | +2.1% | +3.0% | +2.9% | +4.1% | +3.7% | +3.9% | +1.4% | — |
| Feb 1, 2024 | AMC | 0.53 | 1.01 | +90.2% | 84.82 | -1.4% | -5.4% | -6.9% | -6.4% | -6.6% | -4.9% | -2.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Barrington Research | Maintains | Outperform → Outperform | — | $64.08 | $64.02 | -0.1% | -0.7% | -1.8% | -1.3% | +0.1% | -10.3% |
| Jan 30 | Barrington Research | Maintains | Outperform → Outperform | — | $63.03 | $62.80 | -0.4% | +1.8% | +2.3% | -3.1% | +2.3% | +1.5% |
| Jan 30 | Rosenblatt | Maintains | Buy → Buy | — | $63.03 | $62.80 | -0.4% | +1.8% | +2.3% | -3.1% | +2.3% | +1.5% |
| Jan 26 | Barrington Research | Maintains | Outperform → Outperform | — | $62.05 | $62.33 | +0.5% | +0.1% | -1.1% | -1.4% | +1.6% | +3.4% |
| Jan 22 | Rosenblatt | Maintains | Buy → Buy | — | $62.15 | $62.45 | +0.5% | +0.9% | -0.2% | -0.0% | -1.3% | -1.5% |
| Nov 19 | Rosenblatt | Maintains | Buy → Buy | — | $64.96 | $64.15 | -1.2% | +0.1% | +0.8% | +3.9% | +2.8% | +3.7% |
| Nov 19 | Barrington Research | Maintains | Outperform → Outperform | — | $64.96 | $64.15 | -1.2% | +0.1% | +0.8% | +3.9% | +2.8% | +3.7% |
| Sep 12 | Barrington Research | Maintains | Outperform → Outperform | — | $72.11 | $72.24 | +0.2% | -0.9% | -0.4% | -0.3% | -0.9% | -0.0% |
| Aug 15 | Tigress Financial | Maintains | Buy → Buy | — | $72.53 | $72.60 | +0.1% | +0.4% | +1.8% | +1.8% | +1.2% | +0.4% |
| Aug 1 | Rosenblatt | Maintains | Buy → Buy | — | $75.34 | $73.07 | -3.0% | -7.0% | -3.9% | -3.7% | -4.0% | -4.5% |
Recent Filings
8-K
Dolby Laboratories, Inc. -- 8-K Filing
Dolby Laboratories is reminding investors to monitor its official public disclosure channels, as information released through multiple platforms may constitute material information affecting the stock price.
Apr 30
8-K
Dolby Laboratories, Inc.Class A -- 8-K Filing
Dolby Laboratories filed a Form 8-K indicating a material event or corporate action requiring disclosure to shareholders and the market.
Feb 6
Data updated apr 25, 2026 5:20am
· Source: massive.com